rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2007-11-28
|
pubmed:abstractText |
Phaeochromocytomas are rare but potentially life-threatening neuroendocrine tumours of the adrenal medulla or sympathetic nervous system ganglia. There are no histological features which reliably differentiate benign from malignant phaeochromocytomas. The aim of the study was to evaluate cyclooxygenase (COX)-2 and Bcl-2 as tissue-based biomarkers of phaeochromocytoma prognosis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0309-0167
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
743-51
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17916073-Adolescent,
pubmed-meshheading:17916073-Adrenal Gland Neoplasms,
pubmed-meshheading:17916073-Adult,
pubmed-meshheading:17916073-Aged,
pubmed-meshheading:17916073-Cyclooxygenase 2,
pubmed-meshheading:17916073-Female,
pubmed-meshheading:17916073-Humans,
pubmed-meshheading:17916073-Immunohistochemistry,
pubmed-meshheading:17916073-Kaplan-Meier Estimate,
pubmed-meshheading:17916073-Male,
pubmed-meshheading:17916073-Middle Aged,
pubmed-meshheading:17916073-Neoplasm Recurrence, Local,
pubmed-meshheading:17916073-Pheochromocytoma,
pubmed-meshheading:17916073-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:17916073-Tumor Markers, Biological
|
pubmed:year |
2007
|
pubmed:articleTitle |
Cyclooxygenase-2 expression correlates with phaeochromocytoma malignancy: evidence for a Bcl-2-dependent mechanism.
|
pubmed:affiliation |
Department of Medicine, Queen's University Belfast, Belfast, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|